Guacetisal
Guacetisal is obtained from the esterification of acetylsalicylic acid with guaiacol which has the potential for chronic bronchitis treatment extracted from patent CN 106866420 A.
Product Specifications
CAS Number
[55482-89-8]
UNSPSC
12352005
Hazard Statement
H302
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Guacetisal.html
Purity
99.95
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(OC1=CC=CC=C1OC)C2=CC=CC=C2OC(C)=O
Molecular Formula
C16H14O5
Molecular Weight
286.28
Precautions
P264-P270-P330-P501
References & Citations
[1]Li, Junguang, et al. Guacetisal crystal form compound and its preparation method. CN 106866420 A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
KBH13348 1x 96 Well
GENLISA Human Mitogen Activited Protein Kinase 3 (MAPK3/PRKM3) ELISA
Ask
View Details 
RC211114L1V 200 µL
Apolipoprotein L 1 (APOL1) (NM_003661) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 